195 related articles for article (PubMed ID: 35732321)
21. Combined vascular endothelial growth factor and platelet-derived growth factor inhibition in rat cardiac allografts: beneficial effects on inflammation and smooth muscle cell proliferation.
Nykänen AI; Krebs R; Tikkanen JM; Raisky O; Sihvola R; Wood J; Koskinen PK; Lemström KB
Transplantation; 2005 Jan; 79(2):182-9. PubMed ID: 15665766
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of vascular endothelial growth factor expression in clear cell renal cell carcinoma.
Djordjevic G; Mozetic V; Mozetic DV; Licul V; Ilijas KM; Mustac E; Oguic R; Fuckar Z; Jonjic N
Pathol Res Pract; 2007; 203(2):99-106. PubMed ID: 17270362
[TBL] [Abstract][Full Text] [Related]
23. Quantitative analysis of gene expressions of vascular endothelial growth factor-related factors and their receptors in renal cell carcinoma.
Tsuchiya N; Sato K; Akao T; Kakinuma H; Sasaki R; Shimoda N; Satoh S; Habuchi T; Ogawa O; Kato T
Tohoku J Exp Med; 2001 Oct; 195(2):101-13. PubMed ID: 11846206
[TBL] [Abstract][Full Text] [Related]
24. [Molecular tumor board-renal cell carcinoma].
Grünwald V; Doehn C; Goebell PJ
Urologe A; 2019 Jul; 58(7):768-773. PubMed ID: 31175376
[TBL] [Abstract][Full Text] [Related]
25. Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution.
Dhakal HP; McKenney JK; Khor LY; Reynolds JP; Magi-Galluzzi C; Przybycin CG
Am J Surg Pathol; 2016 Feb; 40(2):141-54. PubMed ID: 26752401
[TBL] [Abstract][Full Text] [Related]
26. Effects of chronic hypoxia on renal PDGF-A, PDGF-B, and VEGF gene expression in rats.
Schweda F; Blumberg FC; Schweda A; Nabel C; Holmer SR; Riegger GA; Pfeifer M; Krämer BK
Nephron; 2000 Oct; 86(2):161-6. PubMed ID: 11014986
[TBL] [Abstract][Full Text] [Related]
27. Hypoxia inducible factor-1alpha correlates with vascular endothelial growth factor A and C indicating worse prognosis in clear cell renal cell carcinoma.
Dorević G; Matusan-Ilijas K; Babarović E; Hadzisejdić I; Grahovac M; Grahovac B; Jonjić N
J Exp Clin Cancer Res; 2009 Mar; 28(1):40. PubMed ID: 19302703
[TBL] [Abstract][Full Text] [Related]
28. Platelet-derived growth factor-B enhances glioma angiogenesis by stimulating vascular endothelial growth factor expression in tumor endothelia and by promoting pericyte recruitment.
Guo P; Hu B; Gu W; Xu L; Wang D; Huang HJ; Cavenee WK; Cheng SY
Am J Pathol; 2003 Apr; 162(4):1083-93. PubMed ID: 12651601
[TBL] [Abstract][Full Text] [Related]
29. [Detection and clinical significance of platelet derived growth factor-BB and microvessel density in clear cell renal cell carcinoma].
Qi LF; Sun D; Zheng JH; Du J; Yao X
Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):672-7. PubMed ID: 24332054
[TBL] [Abstract][Full Text] [Related]
30. Gene Expression Profile of Vascular Endothelial Growth Factors (VEGFs) and Platelet-derived Growth Factors (PDGFs) in the Normal Cornea.
Dan Cosnita AR; Raica M; Sava MP; Cimpean AM
In Vivo; 2021; 35(2):805-813. PubMed ID: 33622873
[TBL] [Abstract][Full Text] [Related]
31. Vascular endothelial growth factor-B and vascular endothelial growth factor-C expression in renal cell carcinomas: regulation by the von Hippel-Lindau gene and hypoxia.
Gunningham SP; Currie MJ; Han C; Turner K; Scott PA; Robinson BA; Harris AL; Fox SB
Cancer Res; 2001 Apr; 61(7):3206-11. PubMed ID: 11306510
[TBL] [Abstract][Full Text] [Related]
32. Plasma level and tissue expression of vascular endothelial growth factor in renal cell carcinoma: a prospective study of 50 cases.
Rioux-Leclercq N; Fergelot P; Zerrouki S; Leray E; Jouan F; Bellaud P; Epstein JI; Patard JJ
Hum Pathol; 2007 Oct; 38(10):1489-95. PubMed ID: 17597181
[TBL] [Abstract][Full Text] [Related]
33. Down-regulation of platelet-derived growth factor-D inhibits cell growth and angiogenesis through inactivation of Notch-1 and nuclear factor-kappaB signaling.
Wang Z; Kong D; Banerjee S; Li Y; Adsay NV; Abbruzzese J; Sarkar FH
Cancer Res; 2007 Dec; 67(23):11377-85. PubMed ID: 18056465
[TBL] [Abstract][Full Text] [Related]
34. Inverse regulation of vascular endothelial growth factor and VHL tumor suppressor gene in sporadic renal cell carcinomas is correlated with vascular growth: an in vivo study on 29 tumors.
Brieger J; Weidt EJ; Schirmacher P; Störkel S; Huber C; Decker HJ
J Mol Med (Berl); 1999 Jun; 77(6):505-10. PubMed ID: 10475065
[TBL] [Abstract][Full Text] [Related]
35. Prognostic role of Fuhrman grade and vascular endothelial growth factor in pT1a clear cell carcinoma in partial nephrectomy specimens.
Minardi D; Lucarini G; Mazzucchelli R; Milanese G; Natali D; Galosi AB; Montironi R; Biagini G; Muzzonigro G
J Urol; 2005 Oct; 174(4 Pt 1):1208-12. PubMed ID: 16145371
[TBL] [Abstract][Full Text] [Related]
36. Induction of vascular endothelial growth factor by platelet-activating factor and platelet-derived growth factor is downregulated by corticosteroids.
Nauck M; Roth M; Tamm M; Eickelberg O; Wieland H; Stulz P; Perruchoud AP
Am J Respir Cell Mol Biol; 1997 Apr; 16(4):398-406. PubMed ID: 9115750
[TBL] [Abstract][Full Text] [Related]
37. Down-regulation of vascular endothelial growth factor in renal cell carcinoma cells by glucocorticoids.
Iwai A; Fujii Y; Kawakami S; Takazawa R; Kageyama Y; Yoshida MA; Kihara K
Mol Cell Endocrinol; 2004 Oct; 226(1-2):11-7. PubMed ID: 15489000
[TBL] [Abstract][Full Text] [Related]
38. The platelet-derived growth factor receptor as a target for vascular endothelial growth factor-mediated anti-angiogenetic therapy in head and neck cancer.
Bran B; Bran G; Hörmann K; Riedel F
Int J Oncol; 2009 Jan; 34(1):255-61. PubMed ID: 19082496
[TBL] [Abstract][Full Text] [Related]
39. The von Hippel-Lindau gene product inhibits vascular permeability factor/vascular endothelial growth factor expression in renal cell carcinoma by blocking protein kinase C pathways.
Pal S; Claffey KP; Dvorak HF; Mukhopadhyay D
J Biol Chem; 1997 Oct; 272(44):27509-12. PubMed ID: 9346879
[TBL] [Abstract][Full Text] [Related]
40. Blockade of the vascular endothelial growth factor-receptor 2 pathway inhibits the growth of human renal cell carcinoma, RBM1-IT4, in the kidney but not in the bone of nude mice.
Karashima T; Inoue K; Fukata S; Iiyama T; Kurabayashi A; Kawada C; Shuin T
Int J Oncol; 2007 Apr; 30(4):937-45. PubMed ID: 17332933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
